Expert Q&A: Labs Must Take a Greater Role in Guiding Clinicians About Abnormal Data
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
The first phase in protecting your staff is to carry out an exposure determination to figure out which of your workers are at risk.
A template for creating a general code of conduct that sets out broad parameters and ground rules for compliance.
It’s imperative for labs to establish and maintain an active corporate compliance program that augments the actual scientific testing.
Agency says it will continue to have authority to clear new lab tests and other COVID-19 products on an emergency basis even after the PHE ends.
As we move further into 2023, COVID-19, add-on, and genetic tests will likely remain targets for federal regulators.
A new OIG Advisory Opinion sheds some light on how to properly structure these arrangements in a hospital inpatient setting.
Recent fraud case involving phlebotomy company shows why labs need to pay special attention to Medicare specimen collection and travel allowance rules.
A look at the US end-of-emergency game plan and how it will impact lab compliance.
Sales and marketing operations liability risks and the measures labs should and shouldn’t take to manage those risks.
Economic volatility and uncertainty is also making a significant impact on merger and acquisition activity in the diagnostics space.